Upregulation of CLDN7 has also been reported in ovarian cancer cell lines [30], although the evidence is contradictory, given that downregulation of CLDN7 has been observed in human endometriotic lesions [31] and endometrial cancer, promoting proliferation and metastasis [32]. Here, CLDN7 is linked to ovarian carcinoma.